. H owever, with platelet-rich plasma from some other species, such as the rabbit or pig, ADP does not cause a release reaction (14, 17 (20) . In studies of the effects of inhibitors, 0.1 ml of inhibitor solution was added to 1 ml of platelet suspension before the addition, of ADP in a volume of 0.1 ml. All concentrations given are the final concentrations in the platelet suspension or PRP after all additions. We were also concerned about the effects of traces of titrated plasma carried over during the washing procedure. As little as 0.005 % of titrated platelet-poor plasma in the suspending fluid could give rise to secondary ADP-induced aggregation and release if the platelets were incubated with it for several hours (Fig. 3) . Higher concentrations of citrated platelet-poor plasma (up to 2 %) produced a more rapid onset of the ability of the platelets to undergo ADPinduced secondary aggregation, more extensive release, and fibrin formaticn.
The addition of hirudin to the suspension before incubation with plasma prevented ADP-induced secondary aggregation and release (Fig. 3) .
Effect of thrombin in suspensions of washed platelets. When washed human platelets were exposed to very low concentrations of thrombin (0.017-0.025 U/ml), only l-2 % of the radioactivity from [3H] serotonin-labeled platelets was released; but when ADP was added after the thrombin, considerable release occurred (Table  3 and Fig. 4) . A (Fig. 4 and Table 3 ). The addition of hirudin immediately after the thrombin and ADP inhibited the ADP-induced release of radioactivity from thrombin-stimulated platelets (Table  3 ). This elFfect was observed when hirudin was added at any time up to the point of maximum ADP-induced aggregation.
Fuctor VIII-dejcient plasma. Studies with platelet-rich plasma from a factor VIII-deficient patient showed that ADP-induced secondary aggregation and release of radioactivity from [3H]serotonin-labeled platelets occurred (percentage released with ADP, 0.9 PM, was 31 %; with ADP, 4.5 PM, was 43 %). solutions were subjected to high-speed centrifugation immediately before use. In contrast to the effects of uncentrifuged IgG, when centrifuged IgG solutions were added to suspensions of washed human platelets, ADP caused less aggregation and much less release ( secondary aggregation or release (Table 7) . However, the addition of sodium citrate to the platelet-rich hirudinor heparin-plasma caused AD9 to induce secondary aggregation and release of radioactivity from the [14C]serotoninlabeled platelets.
Effects of calcium and magnesium. Because of the effects caused by sodium citrate, we examined the effect of magnesium and/or calcium in the suspending fluid on ADPinduced aggregation. Figure 6A shows 
